Sign In
Buy COR
$306.28
-2.09 (-0.678%)
At Close: Aug 04, 2026
Cencora (COR) Tops Q4 Earnings and Revenue Estimates
08:46am, Wednesday, 06'th Nov 2024
Cencora (COR) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.21 per share. This compares to earnings of $2.86 per share a year ago.
Cencora to buy Retina Consultants of America for $4.6 bln
06:54am, Wednesday, 06'th Nov 2024
Drug distributor Cencora said on Wednesday it would acquire Retina Consultants of America (RCA) for $4.6 billion in cash, gaining access to its network of eye specialists.
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
06:35am, Wednesday, 06'th Nov 2024
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 billion. Reve
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
06:30am, Wednesday, 06'th Nov 2024
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading management
Cencora to Report Q4 Earnings: What's in Store for the Stock?
01:46pm, Monday, 04'th Nov 2024
COR's fiscal fourth-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
Dividend Aristocrats Of The Future - Part 3
04:42pm, Friday, 01'st Nov 2024
This is the final group of 10 companies scheduled to reach dividend aristocrat status, sometime over the next five years. There are a variety of companies listed, some of whom may not be able to reach
Cencora (COR) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Friday, 01'st Nov 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 30'th Oct 2024
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cencora (COR) is a Top Growth Stock for the Long-Term
10:46am, Monday, 28'th Oct 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
06:00am, Monday, 28'th Oct 2024
VANCOUVER, BC / ACCESSWIRE / October 28, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to provide a summary of the summer drilling and exploratio
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
10:15am, Wednesday, 23'rd Oct 2024
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Why Cencora (COR) is a Top Value Stock for the Long-Term
10:46am, Monday, 21'st Oct 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cencora Rallies 14.7% Year to Date: What's Driving the Stock?
01:06pm, Friday, 18'th Oct 2024
COR is gaining traction from the robust U.S. Healthcare Solutions segment, which raises optimism about the stock.
Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength?
10:10am, Wednesday, 16'th Oct 2024
Cencora (COR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Tuesday, 15'th Oct 2024
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
